Inventiva surges 8%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Inventiva (IVA.US) surged more than 8% during regular trading to $3.675.

The stock is down 20.97% year to date and sits 30.32% above its 52-week low of US$2.820. Volume was 5.92 times its average.

The Nasdaq Composite is down 2.26% over the past five sessions and up 6.67% year to date.

The company released a presentation on preclinical data for Lanifibranor, showing the drug reduced liver fibrosis, improved metabolism and suppressed inflammation through balanced pan-PPAR activation in preclinical models. The findings support further development of the candidate as a treatment for metabolic dysfunction-associated steatohepatitis.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.